Amgen (AMGN) Return on Capital Employed (QoQ) (2009 - 2026)

Amgen (AMGN) Return on Capital Employed (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 187.00
Dec 31, 2025 110.00
Sep 30, 2025 88.00
Jun 30, 2025 101.00
Mar 31, 2025 38.00
Dec 31, 2024 182.00
Sep 30, 2024 2.00
Jun 30, 2024 -45.00
Mar 31, 2024 -122.00
Dec 31, 2023 -159.00
Sep 30, 2023 -106.00
Jun 30, 2023 -122.00
Mar 31, 2023 -530.00
Dec 31, 2022 -81.00
Sep 30, 2022 37.00
Jun 30, 2022 313.00
Mar 31, 2022 193.00
Dec 31, 2021 -44.00
Sep 30, 2021 -48.00
Jun 30, 2021 -194.00